Green v. Wexford Health Sources, Inc.

CourtDistrict Court, S.D. Illinois
DecidedMarch 7, 2023
Docket3:19-cv-00627-JPG
StatusUnknown

This text of Green v. Wexford Health Sources, Inc. (Green v. Wexford Health Sources, Inc.) is published on Counsel Stack Legal Research, covering District Court, S.D. Illinois primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Green v. Wexford Health Sources, Inc., (S.D. Ill. 2023).

Opinion

UNITED STATES DISTRICT COURT FOR THE SOUTHERN DISTRICT OF ILLINOIS

JEROME GREEN,

Plaintiff,

v. Case No. 19-cv-627-JPG

STEPHEN RITZ,

Defendants.

MEMORANDUM AND ORDER GILBERT, District Judge: This matter is before the Court for consideration of a Motion for Summary Judgment filed by Defendant Steven Ritz, D.O. (“Defendant” or “Dr. Ritz”). Plaintiff Jerome Green (“Plaintiff” or “Green”), through counsel, opposes the motion. (Doc. 68). Defendant has filed a reply. (Doc. 69). For the reasons set forth below, the motion shall be DENIED. BACKGROUND This case involves a federal suit for deprivations of constitutional rights pursuant to 42 U.S.C. § 1983. Green alleges he had a swollen keloid on his neck, which Dr. Ritz denied multiple requests for removal and only provided Green with aspirin despite alleged serious pain. (Doc. 6 at 2). The keloid eventually “erupted,” became infected, and Green was only provided with band-aid and tape. Id. Plaintiff suffered with the infected keloid before being referred for outside surgery. Id. Following preliminary review of this matter under 28 U.S.C. § 1915A, the Court dismissed defendant Wexford Health Sources, Inc. (“Wexford”) for a failure to state a claim for relief for deliberate indifference. Green was allowed to proceed with a claim for deliberate indifference against Dr. Ritz, a Wexford employee, for delaying Green’s surgery for removal of his keloid for over a year. (Doc. 6 at 3). DEFENDANT’S MOTION FOR SUMMARY JUDGMENT Dr. Ritz filed for summary judgment on the merits of the claim. Dr. Ritz argues that Green did not suffer from an objectively serious medical condition, and Dr. Ritz was not deliberately indifferent to Green’s serious medical needs under the Eighth Amendment because

he relied on the treatment of other doctors and exercised his own medical judgment in denying Green anything beyond “conservative onsite treatment.” Additionally, Dr. Ritz argues he is shielded from liability by qualified immunity. PLAINTIFF’S RESPONSE Green opposes the motion. Green argues that his keloid was extremely painful, and evidence in the record suggests Dr. Ritz exercised no medical judgment in denying Green’s requests for outside treatment, and his reasons were speculative, pretextual, and contrary to Wexford’s medical guidelines. Additionally, Green argues Dr. Ritz has no claim for qualified immunity because qualified immunity does not apply to private medical personnel in prisons. FACTS

Green is an inmate at Menard Correctional Center (“Menard”). Dr. Ritz was employed by Wexford as Corporate Utilization Management (“UM”) Medical Director. Dr. Robert Smith was a Wexford physician mainly working in UM. Dr. Mohammed Siddiqui (“Dr. Siddiqui”) was employed by Wexford as the Menard Medical Director. UM Physicians review requests for outside treatment, which are reviewed for medical necessity and cost of treatment. Wexford pays for any outside referrals of inmates. Such requests for outside treatment are submitted by site medical directors, and the UM team will have a collegial review to discuss the request. If a request is not agreed upon during the collegial review, an Alternate Treatment Plan (“ATP”) is recommended. Once an ATP is recommended, the date of when the case needs to be readdressed is provided during the collegial call by the UM physician. Once an ATP has recommended, the site director can appeal the ATP, which exists because the treating physician has direct involvement with the patient. Green experienced a keloid on his neck, which is a skin condition caused from

overgrowth of scar tissue, and testified it caused substantial pain. Green testified that by May 29, 2017, he had been expected the pain for nearly a year and a half, and until he was provided surgery in May 2018. The keloid exhibited brown or yellow drainage between April 2018 and May 2018. Additionally, as of May 29, 2017, the keloid had brown discharge and an odor. Green was provided medication for the drainage, and it only changed the color of the drainage to yellow. Menard medical personnel tested the drainage and determined the keloid was infected. Additionally, Dr. Siddiqui testified between April 13, 2017, and July 20, 2017, the keloid was “oozing blood . . . at the base of the keloid.” (Doc. 68 at 9). By November 22, 2017, the keloid was chronically bleeding. Id. Green received gauze and dressings for his keloid everyday between the time of the first referral request and May 2018. However, the keloid grew from 10

cm by 4 cm in April 2017 to 13 cm by 6 cm in May 2018. Id. Green indicated his pain would disrupt his sleep, and his pain was a 9/10. Green also indicated his keloid altered his activities, such as his inability to write his autobiography. He could no longer play cards because other inmates did not want to touch the cards he touched because of the presence of blood and drainage. Green could no longer work because the pain affected his concentration, and the keloid was so heavy it affected his breathing. Additionally, Green would get into fights with cellmates because of the keloid’s odor and blood, which spilled into common areas. Additionally, because he could not chew fast enough during the time allotted because of how the keloid pressed on his throat, he received a feed-in permit. Id. at 10. Plaintiff alleges there were five separate instances of documented denials of treatment. a. April 28, 2017 On April 13, 2017, Green saw a nurse, who noted his keloid was “large” and “sausage- like.” The nurse prescribed an antibiotic for 14 days and sent in a referral request to Wexford

UM for a general surgical consultation. On April 28, 2017, Green saw the nurse again and prescribed another antibiotic for 10 days. On that same day, Dr. Siddiqui and Dr. Ritz discussed the April 13 referral where they denied the referral request and agreed to an ATP to obtain notes about how long the keloid was present, how it impacted Green’s daily activities, and a picture. Dr. Ritz does not recall the treatment plan for the keloid at this time or what the treatment options he considered. On May 29, 2017, Plaintiff was seen in nurse sick call, and he reported stabbing pain and was given Acetaminophen. On June 27, 2017, Plaintiff saw Dr. Siddiqui who directed photos be sent to Dr. Ritz. (Doc. 67 at ¶ 16). b. July 25, 2017 On July 24, 2017,1 Dr. Siddiqui and Dr. Ritz discussed Green’s condition in another

collegial review. On that same day, Dr. Siddiqui appealed Dr. Ritz’s April 28, 2017, denial of surgical consultation. On July 25, 2017, Dr. Ritz denied the surgical consultation. The denial states that photos of the keloid were received, there were no signs of infection or drainage, the keloid was a pre-existing cosmetic condition, the keloid does not meet the IDOC criteria for surgical removal, and the treating physicians should continue to monitor on site and treat symptomatically. Green’s ATP was to treat his symptoms.

1 Defendant indicates that the collegial review occurred on July 20, 2017, and Plaintiff indicates it occurred on July 24, 2017. (Doc. 67 at ¶ 18); (Doc. 68 at 6). c. October 30, 2017 On September 14, 2017, Green was seen by a nurse for the keloid, who charted the presence of drainage, tenderness, pain, but no swelling or redness. Dr. Siddiqui ordered Bactrim DS for 10 days. On October 11, 2017, Green saw the nurse regarding his keloid again and the

nurse charted the keloid was unchanged with no drainage. The nurse prescribed Robaxin for two weeks, and Clinamycin for 7 days. On October 30, Dr. Siddiqui saw Green for the keloid again and Robaxin renewal. Dr. Siddiqui charted “neck-bleeding” and referred Plaintiff to collegial review for a third time.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Gregg v. Georgia
428 U.S. 153 (Supreme Court, 1976)
Estelle v. Gamble
429 U.S. 97 (Supreme Court, 1976)
Anderson v. Liberty Lobby, Inc.
477 U.S. 242 (Supreme Court, 1986)
Donald F. Greeno v. George Daley
414 F.3d 645 (Seventh Circuit, 2005)
Kasten v. Saint-Gobain Performance Plastics Corp.
703 F.3d 966 (Seventh Circuit, 2012)
Farmer v. Brennan
511 U.S. 825 (Supreme Court, 1994)
Gayton v. McCoy
593 F.3d 610 (Seventh Circuit, 2010)
Juan McGee v. Carol Adams
721 F.3d 474 (Seventh Circuit, 2013)
Christopher Pyles v. Magid Fahim
771 F.3d 403 (Seventh Circuit, 2014)
Tyrone Petties v. Imhotep Carter
836 F.3d 722 (Seventh Circuit, 2016)
Anthony Wheeler v. Paul Talbot
695 F. App'x 151 (Seventh Circuit, 2017)
Stallings v. Liping Zhang
607 F. App'x 591 (Seventh Circuit, 2015)

Cite This Page — Counsel Stack

Bluebook (online)
Green v. Wexford Health Sources, Inc., Counsel Stack Legal Research, https://law.counselstack.com/opinion/green-v-wexford-health-sources-inc-ilsd-2023.